Andrew S. Rhinehart, MD, FACP, FACE, CDCES
Chief Executive Officer and Chief Scientific & Medical Officer of Sansum Diabetes Research Institute. Recognized leader in diabetes technology, clinical research, and innovation, with extensive experience leading global trials in continuous glucose monitoring and automated insulin delivery. Former Senior Medical Director at Medtronic Diabetes and advocate for advancing diabetes prevention and care worldwide.